MATERIALS
Bacterial response to subtilin and streptomycin was studied on the Smith strain of M. pyogenes var. aureu8.1 This strain was characterized by a marked virulence for mice.
A purified preparation of subtilin2 and a single lot of streptomycin3 were employed. One-half g of subtilin was weighed and dissolved in 100 ml sterile distilled water to give a concentration of 5,000 ,Ag per ml. The streptomycin was also diluted with sterile, distilled water to a concentration of 5,000 jig per ml.
The aqueous dilutions of the antibiotics were stored in volumes of approximately 10 ml in screw capped test tubes at 5 C. Dilutions of the two antibiotics showed no appreciable loss of potency by the standard assay method here described over a period of several months.
The standard medium for testing bacterial sensitivity to antibiotics contained 3 g beef extract (Difco), 5 g peptone (Difco), and sufficient distilled water to make 1 liter. The reaction was adjusted to pH 7.0. The medium was prepared in large quantities from single lots of peptone and beef extract in order to maintain constancy for each set of assay series.
Biochemical test media were prepared as described elsewhere (Salle, 1948) .
BACTERIAL RESPONSE TO SUBTILIN
Development of subtilin fastness. The general procedure was an adaptation of a previously described method (Salle and Jann, 1948) .
A series of 12 sterile test tubes consisting of 10 assay tubes, a positive growth control, and a sterility control was set up. Ten assay tubes contained in arithmetic progression 0.1 to 1.0 ml of a freshly prepared aqueous dilution of subtilin containing 10 ,ug per ml. The total volume in each tube was adjusted to 1 ml with sterile distilled water. Then 8.9 ml broth and 0.1 ml of a 24-hr broth culture of the organisms were next added to each tube, the contents mixed, and the series incubated at 37 C. Final concentrations of subtilin ranged from 0.1 to 1 ug per ml. In like manner two additional series of assay tubes were set up to give concentrations of subtilin rangg from 1 to 10 and 10 to 50 ug per ml. The assay end point was considered to be the tube containing the greatest concentration of subtilin in which bacterial growth could be seen after a 48-hr incubation. Assay end points were as follows: the 24-hr titer was at a concentration of 0.6 to 0.8 Mug per ml; the 48-hr titer at 0.8 to 1.0 ,g per ml; and the 72-hr titer varied from 1.0 to 2.0 Mug per ml.
In order to develop cultures of increased subtilin fastness, the 48-hr assay end point tubes were used to inoculate again complete series of assay tubes containing the same dilutions of antibiotic. The same procedure was continued through several transfers.
The results achieved through one gradation series of subcultures in subtilin are as follows: the highest dilution of subtilin in which growth of the parent strain could be seen was 1 ,ug per ml; the highest dilution in the second series was 4 ug per ml; and the highest dilution in the third series was 50 ug per ml.
Mouse virulence tests of a subtilin-fast strain. It was considered of importance to determine whether the highly pathogenic Smith strain of M. pyogenes var. aureus for mice had undergone any change in virulence when, through in vitro growth in increasing concentrations of subtilin, the variant resistant strain was developed.
A subtilin-fast strain was maintained by daily transfer over a period of 37 days in broth containing 50 Mg per ml of the antibiotic. One-half ml portions of a 24-hr culture of the bacteria were then seeded into broth containing subtilin in (Kolmer and Boerner, 1945) in a photelometer, then suspensions prepared in normal saline containing approximately 240 and 120 million organisms per ml.
By the same procedure, except for the absence of subtilin in the medium, a 22 to 24-hr culture of the subtilin-sensitive strain of M. pyogenes var. aureus, that had been transferred daily in broth over a period of several months, was prepared and standardized in saline suspensions.
Virulence tests were performed in white mice weighing 18 to 24 g. The infecting dose was, in each case, 1 ml of the standardized saline suspension of bacteria inoculated intraperitoneally.
The mice were examined daily over a period of 14 days. The animals which were inoculated with the subtilin-fast variant displayed no obvious illness syndrome within the first 24 hr after inoculation or subsequently during the 2-week period.
The subtilin-fast variant that had been maintained by daily transfer over a period of 51 days in broth containing 50 ,ug per ml subtilin was subcultured daily for 2 days in subtilin-free broth. Then, by the same procedure described before, a 22 to 24-hr culture of this strain was standardized in saline and inoculated into mice. This strain had also lost its virulence for mice (table 1) .
Stability of the subtilin-fast variant. The variant that had been trained to grow in 50 pAg per ml of subtilin was subcultured daily into broth free of the antibiotic. At intervals over a period of 79 days, the subtilin resistance of the strain was assayed by the standard method previously described. Subtilin fastness was fully retained after as many as 31 daily transfers to media containing no antibiotic. Thereafter, the strain lost some of its resistance. (Salle and Jann, 1948) .
BACTERIAL RESPONSE TO COMBINATIONS OF SUBTILIN AND STREPTOMYCIN
Development of streptomycin resistance in subtilin-fast variant strains. Subtilin-fast variant strains of M. pyogenes var. aureus developed in vitro as described before were subcultured to broth free of subtilin, incubated at 37 C for 24 hr, then assayed for in vitro streptomycin sensitivity by the same procedure used for testing subtilin sensitivity. The streptomycin concentrations ranged in arithmetical progression from 0.1 to 1.0 and 1.0 to 10.0 pg per ml.
The tubes were incubated at 37 C for 48 hr, then examined for turbidity.
An increase in the streptomycin resistance of the subtilin-fast variant of M. pyogenes var. aureus was then effected by an adaptation of the previouslydescribed method for increasing bacterial fastness to subtilin. Antibacterial action of subtilin-8treptomycin combinations. The first experimental procedure was designed to study the action exerted by the 2 antibiotics concurrently in the presence of a constant concentration of subtilin and series of different concentrations of streptomycin. Three series of 9 tubes were set up, each tube containing 8.8 ml broth and 0.1 ml of an aqueous dilution of subtilin containing 7.0 Mg per ml. To each of the three series of tubes was added, respectively, 0.1 to 0.9 ml of freshly prepared aqueous dilutions of streptomycin. Aliquots of a 0.01 Mg per ml concentration were added to the first series; a 0.1 lAg per ml concentration to the second series; and a 1.0 MAg per ml concentration to the third series. The total volume of all tubes was then adjusted to 9.9 ml with sterile distilled water. Finally 0.1 ml of a 24-hr broth culture of the sensitive strain of M. pyogenes var. aureus was added to each tube, the contents mixed, and the tubes incubated at 37 C. The final concentration of subtilin was 0.7 jig per ml. This was the dilution that had been demonstrated, under the same experimental conditions, to be the greatest concentration of subtilin permitting growth of the organism in 24 hr. Final concentrations of streptomycin ranged from 0.001 to 0.009, 0.01 to 0.09, and 0.1 to 0.9 ug per ml. The assay end point was considered to be the tube containing the greatest concentration of the two antibiotics in which growth could be seen after incubation (table 4) .
A reciprocal experimental procedure employing a constant concentration of streptomycin plus various dilutions of subtilin was also performed. A strep- Subcultures of the test organism originally exposed to combinations of subtilin and streptomycin were found to have achieved some increase in both subtilin and streptomycin resistance. The increase in streptomycin resistance was not as marked as that manifested by subcultures from controls that had been exposed to streptomycin alone. However, one instance was noted in which a subculture from an assay end point tube containing streptomycin and a subtilin concentration of 0.7 jug per ml achieved a streptomycin resistance of more than 100 jig per ml.
Specificity of drug fastness. The specificity of in vitro acquired subtilin or streptomycin resistance to the test organism was studied by the following procedure: 24-hr cultures of the organism were incubated in broth containing the various concentrations of each antibiotic alone, as described in the standard method for the study of bacterial drug sensitivity. The 48-hr assay end point tubes were subcultured to broth, and the subcultures incubated at 37 C for 24 hr, then assayed for subtilin-and streptomycin-fastness.
Results indicated that development of resistance to either subtilin or streptomycin was specific and not accompanied by cross-resistance to the other antibiotic.
Nutritional metabolism of drug-fast strains. The ability to ferment mannitol, sucrose, and glucose was not lost by the subtilin-fast and subtilin-streptomycinfast strains of micrococci. Fermentations by the subtilin-resistant strain proceeded equally rapidly in the presence or absence of a 2.0 ,g per ml concentration of subtilin. However, it was noted that fermentation of the subtilin-streptomycin-resistant variants required markedly longer periods of incubation (24 to 48 hr) before acidity was manifested in carbohydrates containing 2.0 ,ug per ml subtilin, and still longer periods (48 to 72 hr) when 2.0 ,g per ml streptomycin was also present.
Gelatin was slowly liquefied (96 to 120 hr) by the drug-sensitive strain. The rate of liquefaction was markedly accelerated by the subtilin-fast variants (24 to 48 hr) while the ability to liquefy gelatin was completely lost by the subtilin-streptomycin-fast variants.
Tests for coagulase and hemolysin production for sheep and human red blood cells were negative for both the drug sensitive strain and for all drug resistant strains of M. pyogenes var. aureus. DISCUSSION Spicer (1950) has demonstrated the effect of antibiotics used in pairs to be one of four types: synergistic, additive, interfering, or indifferent, depending upon the particular combination of drugs used against a given bacterial species. Results reported in the present communication indicate that subtilin does potentiate and complement the action of streptomycin on M. pyogenes var. aureus.
Significantly smaller amounts of each antibio.c were required in the presence of the other to inhibit growth, which is indicative of an additive or synergistic effect. Also, variant strains resistant to the action of either antibiotic were sensitive to the action of the other drug. Warburg respirometer studies on Mycobacterium tuberculosis, strain 599, by Ordanik (1950) have afforded additional evidence of a synergistic action with subtilin-streptomycin combinations. Thatcher (1949) , in studies on the clinical value of streptomycin in synergistic combinations, concluded that, (1) a more effective bacteriostatic action is frequently attained, (2) the danger of development of resistance to a given drug is minimized, which provides opportunity for more prolonged therapy, (3) an organism having resistance to a specific agent may be destroyed by use of a synergistic mixture when the concentration of the drug to which resistance is manifest is a small fraction of the limiting amount that would be required to destroy the organism when used alone, (4) toxicity of a given agent may be reduced since bacteriostasis may be obtained by using a mixture of drugs at lower concentrations than would be required to provide the same degree of bacteriostasis when used alone, and (5) a longer period of treatment, made feasible by using a suitable combination of drugs, improves opportunity for development of maximum titers of immune bodies. The in vitro studies recorded here, when considered together with experimental work previously reported (Salle and Jann, 1949; Ordanik, 1950) , indicate that many or all of these advantages may be anticipated through combined use of subtilin and streptomycin.
The low solubility of subtilin in salt solutions and in serum has presented a difficult problem for the parental administration of the antibiotic. Attempts to resolve this problem have been accomplished by the preparation of modified subtilin solutions of increased solubility through the use of urea (Salle and Jann, 1949) , and through the preparation of subtilin esters, certain of which have shown increased solubility and enhanced activity against Streptococcus faecalis and Micrococcus conglomeratus (Carson et al., 1949 Subtilin-fast variant strains developed in vitro were sensitive to the antibacterial action of streptomycin. They were capable also of developing resistance to streptomycin so that they could be both subtilin and streptomycin-fast at the same time. Development of streptomycin-fastness by subtilin resistant strains was in some instances accompanied by some loss of subtilin-fastness.
Significantly smaller amounts of each antibiotic were required in the presence of the other to inhibit growth of the test sensitive strain of micrococci. Subcultures from the test strain initially exposed to dual concentrations of subtilin and streptomycin manifested some increase in both subtilin and streptomycin resistance. The increase in streptomycin resistance was not as marked as that manifested by subcultures from controls that had been grown in streptomycin broth alone. Results indicated that development of resistance to either subtilin or streptomycin was specific and not accompanied by cross resistance to the other antibiotic. Subtilin-streptomycin-fast variant strains required markedly longer periods of incubation to ferment carbohydrates in the presence of subtilin than did the test sensitive strain of micrococci, or variant strains resistant to subtilin. Even longer incubation periods were required when strains resistant to both antibiotics were incubated in fermentable carbohydrates containing both antibiotics. Subtilinfast variant strains liquefied gelatin in a markedly shorter period of time than was required by the parent sensitive strain. Subtilin-streptomycin-fast variant strains did not liquefy gelatin.
